Wrapping up Q2 earnings, we look at the numbers and key takeaways for the advertising software stocks, including Integral Ad Science (NASDAQ:IAS) and its peers. The digital advertising market is large ...

Ad verification company Integral Ad Science (NASDAQ:IAS) reported Q2 CY2025 results exceeding the market’s revenue expectations , with sales up 15.7% year on year to $149.2 million. Guidance for next ...

Vext Science, Inc. VEXTF VEXT released its financial results for the period ended June 30, 2023, revealing revenue of $9.2 million, an increase of 4.8% compared to $8.8 million in Q2 2022, and an ...

Integral Ad Science (IAS) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.01 per share a year ago. These ...

Thank you for standing by. This is the conference operator. Welcome to the Vext Science Second Quarter 2025 Financial Results Conference Call. [Operator Instructions] The conference call is being ...

NEW YORK (AP) — NEW YORK (AP) — Integral Ad Science Holding Corp. (IAS) on Thursday reported second-quarter net income of $16.4 million. The New York-based company said it had profit of 10 cents per ...

Science Co reported its Q2 2025 earnings, exceeding EPS expectations with a reported €1.37 compared to the forecasted €1.25. The company missed its revenue forecast, posting €1,590 million against an ...

The company's bottom line totaled $73 million, or $1.30 per share. This compares with $82 million, or $1.41 per share, in last year's second quarter. Excluding items, Science Applications ...

Ad verification and measurement provider Integral Ad Science held its first earnings call after going public just over a month ago. Revenue increased 55% to $75.1 million year-over-year. That growth ...

Science Applications International Corp (NYSE: SAIC) reported a 2% revenue growth year over year in the fiscal second quarter of 2025 to $1.82 billion, marginally beating the analyst consensus ...

Leaders at Independence Science and ViewPlus Technologies have announced a collaboration to develop new science access tools for people who experience blindness or low vision. Mike Hingson, ...

A very warm welcome from my side to this Merck Q2 2024 Results Call. My name is Constantin Fest, I'm Head of Investor Relations here at Merck. And I'm delighted to have today here with me Belen Garijo ...